97 publications
Name | Date | Type | Actions |
---|---|---|---|
Buyback programs - November 2023 Monthly communication regarding buyback programs |
04/12/2023 | Description of buyback programs | |
Buyback programs - december 2023 Monthly communication regarding buyback programs |
03/12/2023 | Description of buyback programs | |
Buyback programs - october 2023 Monthly communication regarding buyback programs |
06/11/2023 | Description of buyback programs | |
Sales 3rd quarter 2023: 136M€ The Vetoquinol Group posted sales of €136 million in Q3 2023, up +1.3% on a reported basis and +5.1% at constant exchange rates. Over the same period, Vetoquinol recorded a negative currency impact of -€5 million, linked to the Americas and Asia Pacific/Rest of World territories. |
26/10/2023 | Public releases | |
Buyback programs - September 2023 (french) Monthly communication regarding buyback programs |
04/10/2023 | Description of buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2023 As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
04/10/2023 | Voting rights | |
Sustainable development, an integral part of Vetoquinol Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet". |
13/09/2023 | Press releases communication | |
Rapport financier semestriel 2023 (french) Rapport financier semestriel 2023 (french) |
12/09/2023 | Half Year Report | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2023 As per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
12/09/2023 | Voting rights | |
Buyback programs - August 2023 (french) Monthly communication regarding buyback programs |
12/09/2023 | Description of buyback programs | |
2023 HALF-YEAR RESULTS Sales: €256m (-5.4% as reported) |
07/09/2023 | Public releases | |
2023 Half-Year Results Contents |
07/09/2023 | Half Year Report | |
Buyback programs - July Monthly communication regarding buyback programs |
22/08/2023 | Description of buyback programs | |
Monthly information regarding the total number of voting rights - July 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
22/08/2023 | Voting rights | |
Mastaplex and Vetoquinol announce distribution agreement Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest.. |
27/07/2023 | Press releases communication | |
Update July 11, 2023 2023 CALENDAR OF FINANCIAL COMMUNICATION Update July 11, 2023 |
12/07/2023 | Agenda | |
Rapport financier semestriel 2022 (french) Rapport financier semestriel 2022 (french) |
26/06/2023 | Half Year Report | |
Growth driven by innovation Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy. |
13/06/2023 | Press releases communication | |
Rémunération et politique des dirigeants - mai 2023 (french) Rémunération et politique des dirigeants |
07/06/2023 | Shareholders´s Meeting | |
Vetoquinol - assemblée générale mixte - 25 mai 2023 : résultat du scrutin |
26/05/2023 | Shareholders´s Meeting | |
3rd generation appointed chairman of the board of directors of VETOQUINOL SA At the Combined General Meeting it was also announced that Mr. Etienne Frechin will resign as Chairman of the Board of Vetoquinol, effective 1st July 2023. Mr. Etienne Frechin will remain a Director of the company, hence continuing to share his broad experience. On 25 May 2023, the Board of Directors appointed Mr. Matthieu Frechin, Chief Executive Officer of the Group, as Chairman of the Board of Directors of Vetoquinol effective 1st July 2023. |
25/05/2023 | Press releases communication | |
Assemblée générale - Vetoquinol SA 25 mai 2023 Ordre du jour : |
25/05/2023 | Shareholders´s Meeting | |
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – record date Conformément aux dispositions des articles L233-8-II du Code de Commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers |
24/05/2023 | Shareholders´s Meeting | |
Universal registration document 2022 Universal Registration Document including the Annual Financial Report |
05/05/2023 | Reference document | |
Essential products Essential products for the most common needs |
27/04/2023 | Press releases communication | |
Worlds Top 10 The animal health company is firmly established in the world's Top 10. |
27/04/2023 | Press releases communication | |
Q1 2023 Sales: €145M Vetoquinol recorded sales of €145 million for the first three months of the 2023 financial year, up 7.7% on a reported basis and 7.2% at constant exchange rates. |
20/04/2023 | Public releases | |
BALO : Avis de convocation / avis de réunion Mesdames et Messieurs les actionnaires sont convoqués le jeudi 25 mai 2023 à 11h00 au siège social, Magny-Vernois 70200 LURE, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions ci-après. |
14/04/2023 | Shareholders´s Meeting | |
Document d’enregistrement universel (URD) 2022 version XBRL Document d'enregistrement universel 2022 incluant le rapport financier annuel |
13/04/2023 | Reference document | |
Availability of the 2022 universal registration document On 13 April 2023, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
13/04/2023 | Public releases | |
Monthly information regarding the total number of voting rights - March 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
05/04/2023 | Voting rights | |
Monthly information regarding the total number of voting rights - April 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
05/04/2023 | Voting rights | |
Monthly information regarding the total number of voting rights - May 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
05/04/2023 | Voting rights | |
Monthly information regarding the total number of voting rights - June 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers» |
05/04/2023 | Voting rights | |
Buyback programs – March 2023 Monthly communication regarding buyback programs |
05/04/2023 | Monthly communication regarding buyback programs | |
Clone of Buyback programs – April 2023 Monthly communication regarding buyback programs |
05/04/2023 | Monthly communication regarding buyback programs | |
Buyback programs – May 2023 Monthly communication regarding buyback programs |
05/04/2023 | Monthly communication regarding buyback programs | |
Buyback programs – June 2023 Monthly communication regarding buyback programs |
05/04/2023 | Monthly communication regarding buyback programs | |
A visionary strategy The key steps of a visionary strategy |
03/04/2023 | Press releases communication | |
[VIDEO] Présentation des résultats annuels 2022 -French Présentation analystes & investisseurs - 23 Mars 2023 |
23/03/2023 | Annual Report | |
ANNUAL RESULTS 2022 (slideshow) 01.2022 Highlights |
23/03/2023 | Annual Report | |
2022 ANNUAL RESULTS Annual sales: €540m (up 3.6% as reported) |
23/03/2023 | Public releases | |
Serving animal Health - 90 years Serving animal Health for over 90 years |
06/03/2023 | Press releases communication | |
Monthly information regarding the total number of voting rights - February 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the « Reglement Général de L’Autorité des Marchés Financiers » |
06/03/2023 | Voting rights | |
Buyback programs - February 2023 Monthly communication regarding buyback programs |
06/03/2023 | Description of buyback programs | |
Monthly information regarding the total number of voting rights - January 2023 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
07/02/2023 | Voting rights | |
Buyback programs - January 2023 Monthly communication regarding buyback programs |
07/02/2023 | Description of buyback programs | |
In 2023 Vetoquinol celebrates its 90th anniversary. - 90 years The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health. |
31/01/2023 | Press releases communication | |
Annual sales 2022 Total group Sales: €540 million (up 3.6% as reported) |
18/01/2023 | Public releases | |
CALENDAR 2023 Stock exchange market – non authorized periods The "negative windows" are the abstention periods during which it is forbidden to trade in the Company's securities. |
13/01/2023 | Financial Documents | |
2023 calendar of financial communication Vetoquinol published its calendar of financial communication for 2023. |
10/01/2023 | Agenda | |
Monthly information regarding the total number of voting rights - december 2022 As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers » |
05/01/2023 | Voting rights | |
Buyback programs - december 2022 Monthly communication regarding buyback programs |
04/01/2023 | Description of buyback programs | |
Mis en oeuvre des recommandations AFEP/MEDEF du 6 octobre 2008 sur les rémunérations des dirigeants mandataires sociaux des sociétés cotées Lors de sa réunion du 5 décembre 2008, le Conseil d’administration a pris connaissance des recommandations AFEP-MEDEF du 8 octobre 2008 sur la rémunération des dirigeants sociaux des sociétés cotées. |
22/12/2008 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
10/12/2008 | Voting rights | |
Programme de rachat - novembre 2008 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
10/12/2008 | Monthly communication regarding buyback programs | |
Rapport du président sur le fonctionnement du conseil d’administration et sur le contrôle des procédures internes En application de l’article L. 225-37 du Code de commerce, Monsieur Etienne Frechin, Président-Directeur Général du Groupe Vétoquinol, rend compte dans le cadre du présent rapport « des conditions de préparation et d’organisation des travaux du conseil ainsi que des procédures de contrôle interne mises en place par la société ». |
05/12/2008 | Report on internal control and corporate governance | |
Vétoquinol strengthens its position in Europe with the acquisition of Ascor Chimici in Italy Vétoquinol announces the signing of a contract to acquire 100 percent of the shares of Ascor Chimici S.r.l, which will take effect on 1 December 2008. |
25/11/2008 | Public releases | |
2009 calendar of financial communication Vétoquinol publishes its calendar of financial communication for 2009. |
18/11/2008 | Agenda | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/11/2008 | Voting rights | |
Programme de rachat - octobre 2008 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
07/11/2008 | Monthly communication regarding buyback programs | |
Revenues for the first nine months of 2008 Revenues increased by 3.1% during the first 9 months of 2008 to 171.2 million euros (4.8% on a like-for-like basis). |
22/10/2008 | Public releases | |
Programme de rachat - septembre 2008 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
08/10/2008 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/10/2008 | Voting rights | |
Rapport semestriel Vétoquinol 2008 (french) Vétoquinol a réalisé de bons résultats au premier semestre 2008 : le chiffre d’affaires |
07/10/2008 | Annual Report | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
04/09/2008 | Voting rights | |
Vétoquinol: H1 2008 interim earnings |
27/08/2008 | Annual Report | |
Vétoquinol: 2008 results expected to be in line with objectives At its meeting of 25 August 2008, the Board of Directors of Vétoquinol S.A. reviewed the Group’s operations and approved the financial statements for |
27/08/2008 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
25/08/2008 | Voting rights | |
2008 Interim Revenues increase by 5% Vétoquinol generated revenues of 116.7 million euros in the first half of 2008, a 5% increase over the 111.1 million euros |
22/07/2008 | Public releases | |
Bilan semestriel des moyens alloués au contrat de liquidité (2008) - french Au 30 juin 2008 |
10/07/2008 | Liquidity contract | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/07/2008 | Voting rights | |
Pierre Konareff est nommé Directeur Financier et Juridique du Groupe Vétoquinol (french) Vétoquinol annonce la nomination de Pierre Konareff au poste de Directeur Financier et Juridique du groupe. |
08/07/2008 | Public releases | |
Vétoquinol strengthens its presence in Canada in the compagnion animal market Vétoquinol announces the acquisition of the animal health business assets of VETCOM 1979 INC. The animal health business of VETCOM 1979 INC. includes annual revenue of around CAD1.5 million. The company covers nearly 65% of the market for ophthalmological unguents in Canada. |
01/07/2008 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
11/06/2008 | Voting rights | |
Programme de rachat - mai 2008 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
31/05/2008 | Monthly communication regarding buyback programs | |
Assemblée générale mixte des actionnaires du 19 mai 2008 (french) Résultat du vote des résolutions |
20/05/2008 | Shareholders´s Meeting | |
Activity Report 2007 |
19/05/2008 | Annual Report | |
Financial report 2007 Consolidated 2007 figures are even better than the targets in the business plan we presented for the initial public offering (IPO) in November 2006. |
15/05/2008 | Reference document | |
Monthly information regarding the total number of voting rights and shares making of the share capital as per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
15/05/2008 | Voting rights | |
Satisfactory revenue growth for 1st quarter 2008: +4.6% on a constant basis Revenue for the first quarter of 2008 reached €54.7 M, an increase of 3.0% over the first quarter of 2007, a high revenue growth period. First quarter 2008 growth was particularly significant for the livestock segment. |
06/05/2008 | Public releases | |
Programme de rachat - avril 2008 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
01/05/2008 | Monthly communication regarding buyback programs | |
Rapport de gestion du Conseil d'Administration et texte des résolutions (french) Les chiffres consolidés de l’exercice 2007 sont supérieurs à notre modèle économique qui a été présenté lors de l’introduction en bourse en novembre 2006. Le chiffre d’affaires s’est accru de 10,3% par rapport à l’exercice précédent, incluant une progression de 7,6% |
25/04/2008 | Shareholders´s Meeting | |
Assemblées d'actionnaires et de porteurs de parts (french) Mesdames et Messieurs les actionnaires sont convoqués le Lundi 19 mai 2008 à 15h30, au Centre Culturel François Mitterrand, 29 rue Albert Mathiez, 70200 Lure, en assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions suivants... |
21/04/2008 | Shareholders´s Meeting | |
Programme de rachat - mars 2008 (french) Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
17/04/2008 | Monthly communication regarding buyback programs | |
2007 annual earnings Vétoquinol |
19/03/2008 | Annual Report | |
Earnings for 2007 attest to strength of business growth model The Vétoquinol board of directors, meeting on February 22, 2008, reviewed the group’s business in 2007 and approved the related financial statements. In 2007, Vétoquinol once again achieved significant improvement in its key performance |
18/03/2008 | Public releases | |
VÉTOQUINOL S.A. and JUROX PTY LTD extend their collaboration on ALFAXAN® in Europe |
17/03/2008 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital |
07/03/2008 | Voting rights | |
Déclaration liée à la réalisation d’un programme de rachats d’actions - Période du 18 au 22 février 2008 (french) |
03/03/2008 | Monthly communication regarding buyback programs | |
KIBOW BIOTECH INC. et Vétoquinol S.A. étendent leur accord de commercialisation et de licence vétérinaire pour des applications mondiales (french) |
25/02/2008 | Public releases | |
Déclaration liée à la réalisation d’un programme de rachats d’actions - Janvier 2008 (french) |
18/02/2008 | Monthly communication regarding buyback programs | |
Déclaration liée à la réalisation d’un programme de rachats d’actions - Période du 11 au 15 février 2008 (french) |
18/02/2008 | Monthly communication regarding buyback programs | |
Déclaration liée à la réalisation d’un programme de rachats d’actions - Novembre 2007 (french) |
18/02/2008 | Monthly communication regarding buyback programs | |
Monthly information regarding the total number of voting rights and shares making of the share capital |
12/02/2008 | Voting rights | |
Revenue grows by 10.3% in 2007, to €233.4 M |
24/01/2008 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital |
09/01/2008 | Voting rights |